Literature DB >> 827304

Cytolytic effects of the complement cleavage product, C3a.

J Ferluga, H U Schorlemmer, L C Baptista, A C Allison.   

Abstract

Purified C3a, a cleavage product of the third component of complement,was incubated with various cell types of human and mouse origin. All the tumour cell types tested were lysed by low concentrations of C3a, whereas normal human lymphocytes were relatively resistant. No lysis was produced by C3 or C3b. The possible role of C3a in immunity against tumours is discussed.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 827304      PMCID： PMC2025225          DOI： 10.1038/bjc.1976.223

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  30 in total

1.  A transplantable mast-cell neoplasm in the mouse.

Authors:  T B DUNN; M POTTER
Journal:  J Natl Cancer Inst       Date:  1957-04       Impact factor: 13.506

2.  Continuous subcultivation of epithelial-like cells from normal human tissues.

Authors:  R S M CHANG
Journal:  Proc Soc Exp Biol Med       Date:  1954-11

3.  Human lymphoblastoid cell lines. 3. Co-cultivation technique for establishment of new lines.

Authors:  C M Steel
Journal:  J Natl Cancer Inst       Date:  1972-03       Impact factor: 13.506

Review 4.  Cytotoxic effects of lymphoid cells in vitro.

Authors:  P Perlmann; G Holm
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

5.  Interaction of human anaphylatoxin C3a with rat mast cells demonstrated by immunofluorescence.

Authors:  B ter Laan; J L Molenaar; T M Feltkamp-Vroom; K W Pondman
Journal:  Eur J Immunol       Date:  1974-05       Impact factor: 5.532

Review 6.  Cell-mediated cytotoxicity, allograft rejection, and tumor immunity.

Authors:  J C Cerottini; K T Brunner
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

7.  Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase.

Authors:  V A Bokisch; H J Müller-Eberhard
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

8.  Gross and ultrastructural observations on lesions produced by intradermal injection of human C3a in man.

Authors:  I H Lepow; K Willms-Kretschmer; R A Patrick; F S Rosen
Journal:  Am J Pathol       Date:  1970-10       Impact factor: 4.307

9.  Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines.

Authors:  G J TODARO; H GREEN
Journal:  J Cell Biol       Date:  1963-05       Impact factor: 10.539

10.  The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.

Authors:  C G Cochrane; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1968-02-01       Impact factor: 14.307
View more
  8 in total

Review 1.  The role of macrophage activation in chronic inflammation.

Authors:  A C Allison; J Ferluga; H Prydz; H U Schorlemmer
Journal:  Agents Actions       Date:  1978-01

2.  Production of the complement cleavage product, C3a, by activated macrophages and its tumorolytic effects.

Authors:  J Ferluga; H U Schorlemmer; L C Baptista; A C Allison
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

3.  Macrophage secretion and the complement cleavage product C3a in the pathogenesis of infections by mycoplasmas and L-forms of bacteria and in immunity to these organisms.

Authors:  D Taylor-Robinson; H U Schorlemmer; P M Furr; A C Allison
Journal:  Clin Exp Immunol       Date:  1978-09       Impact factor: 4.330

4.  Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release.

Authors:  M M Glovsky; T E Hugli; T Ishizaka; L M Lichtenstein; B W Erickson
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

5.  Studies on the mechanisms of macrophage activation. I. Destruction of intracellular Leishmania enriettii in macrophages activated by cocultivation with stimulated lymphocytes.

Authors:  J Mauel; Y Buchmüller; R Behin
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

6.  Cytolysis of fibroblasts by C3a.

Authors:  A Temple; A C Allison
Journal:  Br J Cancer       Date:  1980-07       Impact factor: 7.640

7.  Tumour-necrosis factor from the rabbit. I. Mode of action, specificity and physicochemical properties.

Authors:  N Matthews; J F Watkins
Journal:  Br J Cancer       Date:  1978-08       Impact factor: 7.640

8.  Intense tumour-cell destruction by syngeneic mice: role of macrophages, complement activation and tumour-cell factors.

Authors:  S Orbach-Arbouys; J Lheritier; M Allouche; P Pouillart
Journal:  Br J Cancer       Date:  1977-12       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.